Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone

PA tag: A versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin

(2014) Yuki Fujii et al.   PROTEIN EXPRESSION AND PURIFICATION

A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation

(2013) Yukinari Kato et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations

(2013) Mika Kato Kaneko et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Generation of a novel monoclonal antibody WMab-1 specific for IDH2-R172W mutation

(2013) Yukinari Kato et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome

(2013) Kunihiko Moriya et al.   CANCER SCIENCE

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

(2013) Sam Behjati et al.   NATURE GENETICS

Establishment of a Multi-Specific Monoclonal Antibody MsMab-1 Recognizing Both IDH1 and IDH2 Mutations

(2013) Mika Kato Kaneko et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1

(2013) Xing Liu et al.   Cancer Medicine

Giant cell tumor of bone: A basic science perspective

(2012) Robert W. Cowan et al.   BONE

Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors

(2012) Shingo Takano et al.   JOURNAL OF NEURO-ONCOLOGY

Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation

(2011) Mika Kato Kaneko et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

(2011) Twinkal C Pansuriya et al.   NATURE GENETICS

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

(2010) Patrick S. Ward et al.   CANCER CELL

Denosumab: a breakthrough in treatment of giant-cell tumour of bone?

(2010) Maurice Balke et al.   LANCET ONCOLOGY

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

(2009) Yukinari Kato et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

(2009) Lenny Dang et al.   NATURE

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE